Back
Cormedix 10K Form
Buy
73
CRMD
Cormedix
Last Price:
$12.75
Seasonality Move:
6.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-14 | 10Q | CRMD/Cormedix Quarterly |
2023-08-08 | 10Q | CRMD/Cormedix Quarterly |
2023-05-15 | 10Q | CRMD/Cormedix Quarterly |
2022-11-10 | 10Q | CRMD/Cormedix Quarterly |
2022-08-11 | 10Q | CRMD/Cormedix Quarterly |
2022-05-12 | 10Q | CRMD/Cormedix Quarterly |
Receive CRMD News And Ratings
See the #1 stock for the next 7 days that we like better than CRMD
CRMD Financial Statistics
Sales & Book Value
Annual Sales: | $43.5M |
---|---|
Cash Flow: | $19.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.70 |
Price / Book: | 7.53 |
Profitability
EPS (TTM): | 0.22000 |
---|---|
Net Income (TTM): | $17.2M |
Gross Margin: | $40.3M |
Return on Equity: | 23.7% |
Return on Assets: | 18.21% |
Cormedix Earnings Forecast
Key Cormedix Financial Ratios
-
The Gross Profit Margin over the past 16 years for CRMD is 92.66%.
-
The Selling, General & Administrative Expenses for CRMD have been equal to 135.02% of Gross Profit Margin.
-
The Research & Development expenses have been 9.07% of Revenue.
-
The Net Earning history of CRMD is -41.24% of Total Revenues.
-
Per Share Earnings over the last 16 years have been positive in 10 years.
Cormedix Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | CRMD |
CUSIP: | 21900C |
Website: | cormedix.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.21 |
Quick Ratio: | 3.84 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 8.45 |